167 related articles for article (PubMed ID: 25016356)
41. [gamma-Hydroxybutyrate intoxication].
Hahne N; Weinmann W; Nebel BW
Anaesthesist; 2004 Oct; 53(10):950-4. PubMed ID: 15243711
[TBL] [Abstract][Full Text] [Related]
42. The clinical toxicology of γ-hydroxybutyrate, γ-butyrolactone and 1,4-butanediol.
Schep LJ; Knudsen K; Slaughter RJ; Vale JA; Mégarbane B
Clin Toxicol (Phila); 2012 Jul; 50(6):458-70. PubMed ID: 22746383
[TBL] [Abstract][Full Text] [Related]
43. Self-medication with gamma-hydroxybutyrate to reduce alcohol intake.
Glisson JK; Norton J
South Med J; 2002 Aug; 95(8):926-8. PubMed ID: 12190234
[TBL] [Abstract][Full Text] [Related]
44. Clinical features and management of gamma-hydroxybutyrate (GHB) withdrawal: a review.
McDonough M; Kennedy N; Glasper A; Bearn J
Drug Alcohol Depend; 2004 Jul; 75(1):3-9. PubMed ID: 15225884
[TBL] [Abstract][Full Text] [Related]
45. [Gamma-hydroxybutyrate--an endogenous substance and a new central nervous system stimulant. Clinical aspects of acute poisoning].
Engelsen J; Christensen HR
Ugeskr Laeger; 1999 Dec; 161(50):6903-7. PubMed ID: 10643375
[TBL] [Abstract][Full Text] [Related]
46. Severe gamma-hydroxybutyrate withdrawal: a case report and literature review.
Craig K; Gomez HF; McManus JL; Bania TC
J Emerg Med; 2000 Jan; 18(1):65-70. PubMed ID: 10645841
[TBL] [Abstract][Full Text] [Related]
47. [GHB--dangerous, addictive and uncontrollable "party drug"].
Persson SA; Eriksson A; Hallgren N; Eklund A; Berkowicz A; Druid H
Lakartidningen; 2001 Sep; 98(38):4026-31, 4033-5. PubMed ID: 11602959
[TBL] [Abstract][Full Text] [Related]
48. [Gamma-hydroxybutyric acid (GHB) dependence and the GHB withdrawal syndrome: diagnosis and treatment].
van Noorden MS; Kamal R; de Jong CA; Vergouwen AC; Zitman FG
Ned Tijdschr Geneeskd; 2010; 154():A1286. PubMed ID: 21040601
[TBL] [Abstract][Full Text] [Related]
49. A case of psychosis and delirium following withdrawal from triazolam.
Heritch AJ; Capwell R; Roy-Byrne PP
J Clin Psychiatry; 1987 Apr; 48(4):168-9. PubMed ID: 3558332
[TBL] [Abstract][Full Text] [Related]
50. Depression Following γ-Hydroxybutyrate Withdrawal: A Case Report.
Domínguez I; Bruguera P; Balcells-Oliveró M; Batalla A
J Clin Psychopharmacol; 2015 Oct; 35(5):618-9. PubMed ID: 26284931
[No Abstract] [Full Text] [Related]
51. [Gamma-hydroxybutyrate for treatment of alcohol withdrawal syndrome in intensive care patients. A comparison between with two symptom-oriented therapeutic concepts].
Lenzenhuber E; Müller C; Rommelspacher H; Spies C
Anaesthesist; 1999 Feb; 48(2):89-96. PubMed ID: 10093649
[TBL] [Abstract][Full Text] [Related]
52. Within-patient variability in clinical presentation of gamma-hydroxybutyrate withdrawal: a case report.
Glasper A; McDonough M; Bearn J
Eur Addict Res; 2005; 11(3):152-4. PubMed ID: 15990433
[TBL] [Abstract][Full Text] [Related]
53. Gamma-hydroxybutyrate withdrawal syndrome.
Dyer JE; Roth B; Hyma BA
Ann Emerg Med; 2001 Feb; 37(2):147-53. PubMed ID: 11174231
[TBL] [Abstract][Full Text] [Related]
54. Chemical submission: GHB, benzodiazepines, and other knock out drops.
Bismuth C; Dally S; Borron SW
J Toxicol Clin Toxicol; 1997; 35(6):595-8. PubMed ID: 9365425
[No Abstract] [Full Text] [Related]
55. A case of Baclofen withdrawal induced psychosis treated with lorazepam.
Leandre F; Ginory A
Aust N Z J Psychiatry; 2019 Feb; 53(2):174. PubMed ID: 30387363
[No Abstract] [Full Text] [Related]
56. Medical and legal confusion surrounding gamma-hydroxybutyrate (GHB) and its precursors gamma-butyrolactone (GBL) and 1,4-butanediol (1,4BD).
Wood DM; Warren-Gash C; Ashraf T; Greene SL; Shather Z; Trivedy C; Clarke S; Ramsey J; Holt DW; Dargan PI
QJM; 2008 Jan; 101(1):23-9. PubMed ID: 18203723
[TBL] [Abstract][Full Text] [Related]
57. Gamma-hydroxybutyric acid: an emerging recreational drug.
Kam PC; Yoong FF
Anaesthesia; 1998 Dec; 53(12):1195-8. PubMed ID: 10193223
[TBL] [Abstract][Full Text] [Related]
58. Acute toxicity and withdrawal syndromes related to γ-hydroxybutyrate (GHB) and its analogues γ-butyrolactone (GBL) and 1,4-butanediol (1,4-BD).
Wood DM; Brailsford AD; Dargan PI
Drug Test Anal; 2011; 3(7-8):417-25. PubMed ID: 21548140
[TBL] [Abstract][Full Text] [Related]
59. Management of gamma-hydroxybutyrate withdrawal.
Sharma AN; Lombardi MH; Illuzzi FA; Nelson LS
Ann Emerg Med; 2001 Nov; 38(5):605-7. PubMed ID: 11679881
[No Abstract] [Full Text] [Related]
60. [GHB abuse in a pregnant patient in clinical practice].
Santy T; Heylens G; Audenaert K
Tijdschr Psychiatr; 2020; 62(10):896-900. PubMed ID: 33184821
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
